Gyorgy Szabadkai

Gyorgy Szabadkai

Auto-generated profile, based on publicly available information

Gyorgy Szabadkai

Department of Cell and Developmental Biology and Consortium for Mitochondrial Research, University College London, London, UK

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Physiology
Verified
Journal Article
Closed access
PDF file
GSGyörgy Szabadkai
György Szabadkai
MDMichael R. Duchen
Michael R. Duchen
Mitochondria couple cellular metabolic state with Ca2+transport processes. They therefore control not only their own intra-organelle [Ca2+], but they also influence the entire cellular network of cellular Ca2+signaling, including the endoplasmic reticulum, the plasma membrane, and the nucleus. Through the detailed study of mitochondrial roles in Ca2+signaling, a remarkable picture of inter-organelle communication has emerged. We here review the ways in which this system provides integrity and flexibility for the cell to cope with the countless demands throughout its life cycle and discuss briefly the mechanisms through which it can also drive cell death.

18 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
RDRadha Desai
Radha Desai
DEDaniel A. East
Daniel A. East
LHLiana Hardy
Liana Hardy
DFDanilo Faccenda
Danilo Faccenda
MRManuel Rigon
Manuel Rigon
MCMichelangelo Campanella
Michelangelo Campanella
Physical tethering between mitochondria and nucleus sustains retrograde response.

5 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TBThomas Briston
Thomas Briston
MRMalcolm Roberts
Malcolm Roberts
SLSian Lewis
Sian Lewis
BPBen Powney
Ben Powney
JSJames M. Staddon
James M. Staddon
MDMichael R. Duchen
Michael R. Duchen
Mitochondrial Ca2+ uptake has a key role in cellular Ca2+ homeostasis. Excessive matrix Ca2+ concentrations, especially when coincident with oxidative stress, precipitate opening of an inner mitochondrial membrane, high-conductance channel: the mitochondrial permeability transition pore (mPTP). mPTP opening has been implicated as a final cell death pathway in numerous diseases and therefore understanding conditions dictating mPTP opening is crucial for developing targeted therapies. Here, we have investigated the impact of mitochondrial metabolic state on the probability and consequences of mPTP opening. Isolated mitochondria were energised using NADH- or FADH2-linked substrates. The functional consequences of Ca2+-induced mPTP opening were assessed by Ca2+ retention capacity, using fluorescence-based analysis, and simultaneous measurements of mitochondrial Ca2+ handling, membrane potential, respiratory rate and production of reactive oxygen species (ROS). Succinate-induced, membrane potential-dependent reverse electron transfer sensitised mitochondria to mPTP opening. mPTP-induced depolarisation under succinate subsequently inhibited reverse electron transfer. Complex I-driven respiration was reduced after mPTP opening but sustained in the presence of complex II-linked substrates, consistent with inhibition of complex I-supported respiration by leakage of matrix NADH. Additionally, ROS generated at complex III did not sensitise mitochondria to mPTP opening. Thus, cellular metabolic fluxes and metabolic environment dictate mitochondrial functional response to Ca2+ overload.

21 October 2011 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
JTJ Traba
J Traba
AAA del Arco
A del Arco
MDM R Duchen
M R Duchen
GSG Szabadkai
G Szabadkai
JSJorgina Satrustegui
Jorgina Satrustegui
Ca2+-mediated mitochondrial permeability transition (mPT) is the final common pathway of stress-induced cell death in many major pathologies, but its regulation in intact cells is poorly understood. Here we report that the mitochondrial carrier SCaMC-1/SLC25A24 mediates ATP-Mg2−/Pi2− and/or HADP2−/Pi2− uptake into the mitochondria after an increase in cytosolic [Ca2+]. ATP and ADP contribute to Ca2+ buffering in the mitochondrial matrix, resulting in desensitization of the mPT. Comprehensive gene expression analysis showed that SCaMC-1 overexpression is a general feature of transformed and cancer cells. Knockdown of the transporter led to vast reduction of mitochondrial Ca2+ buffering capacity and sensitized cells to mPT-mediated necrotic death triggered by oxidative stress and Ca2+ overload. These findings revealed that SCaMC-1 exerts a negative feedback control between cellular Ca2+ overload and mPT-dependent cell death, suggesting that the carrier might represent a novel target for cancer therapy.

27 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
BBBenoit Bilanges
Benoit Bilanges
SASamira Alliouachene
Samira Alliouachene
WPWayne Pearce
Wayne Pearce
DMDaniele Morelli
Daniele Morelli
GSGyorgy Szabadkai
Gyorgy Szabadkai
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
Vps34 PI3K is thought to be the main producer of phosphatidylinositol-3-monophosphate, a lipid that controls intracellular vesicular trafficking. The organismal impact of systemic inhibition of Vps34 kinase activity is not completely understood. Here we show that heterozygous Vps34 kinase-dead mice are healthy and display a robustly enhanced insulin sensitivity and glucose tolerance, phenotypes mimicked by a selective Vps34 inhibitor in wild-type mice. The underlying mechanism of insulin sensitization is multifactorial and not through the canonical insulin/Akt pathway. Vps34 inhibition alters cellular energy metabolism, activating the AMPK pathway in liver and muscle. In liver, Vps34 inactivation mildly dampens autophagy, limiting substrate availability for mitochondrial respiration and reducing gluconeogenesis. In muscle, Vps34 inactivation triggers a metabolic switch from oxidative phosphorylation towards glycolysis and enhanced glucose uptake. Our study identifies Vps34 as a new drug target for insulin resistance in Type-2 diabetes, in which the unmet therapeutic need remains substantial.

1 June 2021 in Cell Reports
Verified
Journal Article
Open access
AMAgnese De Mario
Agnese De Mario
ATAnna Tosatto
Anna Tosatto
JHJulia Marie Hill
Julia Marie Hill
JKJanos Kriston-Vizi
Janos Kriston-Vizi
Robin KettelerRobin Ketteler
Robin Ketteler
Cristina MammucariCristina Mammucari
Cristina Mammucari
The mitochondrial calcium uniporter (MCU), the highly selective channel responsible for mitochondrial Ca2+ entry, plays important roles in physiology and pathology. However, only few pharmacological compounds directly and selectively modulate its activity. Here, we perform high-throughput screening on a US Food and Drug Administration (FDA)-approved drug library comprising 1,600 compounds to identify molecules modulating mitochondrial Ca2+ uptake. We find amorolfine and benzethonium to be positive and negative MCU modulators, respectively. In agreement with the positive effect of MCU in muscle trophism, amorolfine increases muscle size, and MCU silencing is sufficient to blunt amorolfine-induced hypertrophy. Conversely, in the triple-negative breast cancer cell line MDA-MB-231, benzethonium delays cell growth and migration in an MCU-dependent manner and protects from ceramide-induced apoptosis, in line with the role of mitochondrial Ca2+ uptake in cancer progression. Overall, we identify amorolfine and benzethonium as effective MCU-targeting drugs applicable to a wide array of experimental and disease conditions.